A Blast from BIEL's Past circa 2005 Abdominoplasty

New Post Public Reply Private Reply Replies (1) Message Board
swordfish
383
A Blast from BIEL's Past circa 2005

Abdominoplasty Post-Operative Pain Control With ActiPatch, Goh, Kimberley, MD

Grand Strand Plastic and Reconstructive Surgery Center, P.A.
Myrtle Beach, SC 29577

An abdominoplasty is one of the most painful cosmetic body contouring procedures we perform. Fear of post-operative pain has always been an obstacle for patients when considering an abdominoplasty. There is now a new, portable, lightweight and low cost way to decrease postoperative pain. The ActiPatch is a device which produces pulsed electromagnetic therapy that helps reduce swelling, relieve pain and enhance healing.*

I have been using the ActiPatch 500 for postoperative abdominoplasties for about six months and have been very impressed at its pain control. Prior to ActiPatch I had been using oxycodone and diazepam for postoperative pain control with intra-operative marcaine placed under the flap prior to emergence from anesthesia. The patients complained of significant pain and usually needed additional prescriptions for both pain and muscle relaxers within four days of surgery and often again at one week. Since using ActiPatch postoperatively I have not written a supplemental prescription for pain control and they have some left over. Their narcotic and medication needs have now decreased approximately seventy five percent.

Initially four patients were placed on ActiPatch for pain control after abdominoplasties. All patients had standard abdominoplasties with muscle and skin tightening; one had an augment performed as well. The charts were reviewed and interviews performed retrospectively to the physician to evaluate postoperative pain and narcotic use.

The first patient, A., was a 44 year old woman who had three full term pregnancies and several months of nursing. She complained of loss of breast fullness and a saggy abdomen. Physical exam revealed ptosis and pseudoptosis of her breasts and a lax abdominal wall, especially the upper abdomen, and loose skin on the upper and lower abdomen. She underwent a standard abdominoplasty and a bilateral subglandular breast augment. The breast augment was performed using a smooth round saline Mentor implant 350cc filled to 400cc in subglandular position through an inframammary incision. The abdominoplasty resected about 40 X 13 centimeters of skin, and the diastasis recti was corrected (about an eight centimeter plication). Fourteen cc of ¼% marcaine was placed under the flap at closure. As the patient was emerging from anesthesia the ActiPatch 500 was placed on the epigastrum and attached using its adhesive pad directly on the skin.

In recovery she needed one oxycodone for immediate postoperative pain. The evening of surgery she rested comfortably, and on her first visit on postoperative day one she came for her appointment wearing makeup with her hair styled and had minimal complaints of pain. She had been taking only one oxycodone every six hours because she was afraid that it would hurt, but had no complaints of abdominal pain. She had her oxycodone changed to mepergan because of nausea, but used very little her first week. She said she felt "she could have run a marathon" and could not believe how little pain she had.

Patient B was a 30 year old woman with two full term pregnancies who complained of a lax abdomen after multiple pregnancies and a previous cesarean section five years prior. She underwent a standard abdominoplasty. Of note is that she had undergone a scheduled knee surgery two days prior to her abdominoplasty in order to make her recovery simultaneous. At surgery she had a 14 X 46 centimeter skin resection and an eight centimeter tightening of her diastasis recti. Fifteen cc of ¼% marcaine was placed under the flap at closure. The ActiPatch 500 was activated and placed directly on the epigastrum after the wound was closed. In recovery she had one oxycodone given orally. The first evening postop she used less than one oxycodone and one diazepam every six hours. The first day postop she complained only of knee pain, and felt that the abdominoplasty was less painful than her previous cesarean section. She also came in wearing facial cosmetics and had her hair styled on her first day after surgery. Her first week post op she also used less than 20 each of diazepam and oxycodone.

Patient C was a33 year old nulliparous woman with a previous submuscular augment mastopexy who complained of inability to tighten her lower abdomen with diet and exercise. She underwent a standard abdominoplasty with resection of approximately 13 centimeter by 43 centimeter skin ellipse, and an eight centimeter diastasis recti plication. Postoperatively she had an ActiPatch 500 activated and applied to her epigastrum. In the recovery room she had one oxycodone orally for pain. The evening of surgery she took one and one 5 mg diazepam. By the evening of surgery her only pain was on moving to stand or recline. At rest she was pain free and reported less pain than her previous augment mastopexy. The following week she took one or two oxycodone a day.

Patient D was a 56 year old with one full term pregnancy who was interested in improving her saggy lower abdomen. She had a previous lower midline incision for a cesarean section and a right lower quadrant incision for a bone graft donor site. She had significant diastasis recti and a small abdominal pannus. She underwent a standard abdominoplasty with repair of diastasis and right lower quadrant plication for asymmetrical laxity. She had a 15 X 42.5 skin resection and a six centimeter plication. She had 12 cc of ¼% marcaine placed prior to emergence under the flap. Postoperatively she had one ActiPatch 500 device placed on the epigastrum. In the recovery room she had one oxycodone, and the first evening of surgery, one diazepam and one oxycodone. The next few days she was taking one to two diazepam once a day and one oxycodone four times a day. By the end of her first week she had taken about twenty of the oxycodone and even less of the diazepam.

The amount of pain relief with the ActiPatch after a major surgery is impressive. This retrospective review of patients' charts and interviews demonstrates a marked decrease in postoperative pain and use of narcotics in abdominoplasty. While the ActiPatch can assist with healing and reduce swelling, those benefits are difficult to appreciate in actual clinical practice. The amount of pain relief however is easier to evaluate. There is a marked decrease in the use of pain medications and as well as a significant increase in comfort level. It is currently a low cost, small, portable, narcotic free pain control device, and should be considered in all major abdominal surgeries.

Postoperative pain in an abdominoplasty is usually severe, and requires significant amounts of narcotics and muscle relaxers to control. The ActiPatch is a new device that suppresses pain without narcotics. It is a small, disposable, affordable and easily applied external device that is a radiofrequency generator. It has been promoted for decreasing swelling, accelerating wound healing (radiofrequency used in orthopedics to accelerate boney union) and for pain control. Byron Medical is the distributor for plastic surgeons.

I have found that using the ActiPatch for pain control has made a tremendous difference in my patients' recovery after an abdominoplasty. I now use it on all of my abdominoplasties. I started applying it to my abdominoplasty patients in 2003 and some of other patients who were concerned about postoperative pain control, and desired to be off medication sooner to be able to return to work. I have not been comfortable using the pain pumps, especially in those patients who have an implant because of the theoretical potential for introducing bacteria. This is a simpler, cleaner and less expensive way to approach surgical pain.

The response is impressive. I did a retrospective review of my abdominoplasty patients and looked at the number and amount of the pain medication prescriptions. I wrote for about one fourth of the usual amount if I used the ActiPatch. Prior to the ActiPatch they were using about two oxycodone and ten milligrams of valium every four hours the first few days. After I began using the ActiPatch, they were using about one fourth of the drugs in the first week. Also three of these abdominoplasty patients came to my office on the first day postoperatively with makeup on and their hair done. (The other did not wear makeup preop.) That was a first! I was using the ActiPatch 500 applied to the epigastrum in the operating room immediately after the procedure. I have also used it on my breast augment patients and reduction patients that seem to have a lower pain threshold, with good results.

I have had some of my abdominoplasty patients decide that their back bothered them more than their abdomen after a week or so and moved the ActiPatch from their abdomen to their back, and found relief. One got so much relief from her chronic back pain that she came back and bought three for a long trip to New Zealand! She has asked me if I mind her buying it for her back during the year.

ActiPatch for pain control is worthwhile in the postoperative patient, it allows less narcotic use. The cosmetic patient has a great appreciation for the earlier discontinuation of narcotics, and it should be considered for those procedures associated with significant postoperative pain.

https://www.sec.gov/Archives/edgar/data/13208...xh1014.htm page 49

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ian Marx Wins Pro Bono Honor at NJ Legal Awards

Updated Category News Views 81

A Champion in Legal Advocacy How often do we hear about a lawyer choosing the unglamorous path of pro bono work over the high-stakes allure of corporate law? Slam-dunk, you don’t. At the New Jersey Legal Awards, Ian S. Marx from Greenberg Traurig broke the mold, snagging the 'Pro Bono Lawyer of the Year' award. This isn’t just some pat on the back; it's recognition of...

Continue Reading
Seaboard's Q3 Financials: A Mixed Bag for Investors

Updated Category News Views 124

Eyeing Seaboard's Earnings: What's the Deal? Seaboard Corporation just dropped its earnings report for the third quarter, and boy, it's a doozy. The numbers show a mixed bag—like finding out your favorite team won, but your best player got benched with an injury. On the surface, we've got a rise in net sales, but dig a little deeper, and the cracks start to show. Sales...

Continue Reading
SWFI's I20 Summit Spotlights 3,000 Promising Start-Ups

Updated Category News Views 101

Spotlight on Emerging Titans: The Future 100 Watchlist The Sovereign Wealth Fund Institute is rattling the investment cages with their latest stunt, the 'Future 100 Watchlist.' Hot off the press, this list is parading nearly 3,000 start-ups that are biting at the heels of future success. It's high stakes and higher hopes between December 11-16 at Miami's I20 Summit, where...

Continue Reading
Sandals & Beaches Black Friday: Up to 65% Savings

Updated Category News Views 102

Vacation Savings So Sweet They’re Hard to Ignore If you’ve been dreaming of a sun-soaked escape, Sandals and Beaches Resorts have rolled out deals so compelling, they’re practically begging you to pack your bags. This year, from November 3 until December 1, travelers can dive into savings of up to 65% combined with air credits reaching up to $750. In a move clearly...

Continue Reading
Havertys Q3 Upswing Amid Tariffs and Tight Margins

Updated Category News Views 21

Havertys Delivers a Steady Third Quarter Amid Challenges Alright investors, Havertys Furniture (NYSE:HVT) just rolled out its Q3 numbers for 2026 and folks, it looks like this furniture staple is holding its ground pretty well against a backdrop rife with economic headwinds. Quarterly Numbers: A Mix of Hope and Hurdles If you’re keeping score, diluted EPS stepped up...

Continue Reading
Autohome's 2026 Q3 Results: Revenue Dips But Optimism Glows

Updated Category News Views 53

A Rollercoaster Quarter for Autohome Diving right into Autohome's latest financial results, and boy, it's not the cheeriest news we've heard. For Q3 2026, the famed online auto hub's net revenue is down to RMB1,315.0 million from RMB1,778.1 million a year prior. That's a hefty slide in any trader's book. More so, net income attributable to the company tumbled from...

Continue Reading
Memoir 'Pinball' Explores Life's Unpredictable Momentum

Updated Category News Views 91

Funny how some folks think life has a road map. Let me tell you, it's more like a pinball machine, barely controllable and ready to surprise you with a tilt at any moment. And that's the essence of Marshall Barber's new memoir, 'PINBALL: Remembrances of a Flaneur.' Life's Roulette: Choices and Chance Barber takes readers on a raw ride through the byways of a life...

Continue Reading
Maple Leaf Foods' Q3 Results: Growth Amidst Inflation

Updated Category News Views 12

Navigating Inflationary Waters: A Maple Leaf Foods Update Seeing Maple Leaf Foods (TSX: MFI) push through a tough inflationary landscape with a 15.4% rise in EBITDA would make any seasoned investor nod in respect. They've gone from last year's $111.7 million to a hefty $129 million in Q3 2026. What's more, their EBITDA margin climbed to 12.5%, up 140 basis points from...

Continue Reading
Metacon Q3 Report Unveiled Amid Green Hydrogen Buzz

Updated Category News Views 114

Peeling Back Metacon's Q3 2026 Figures Alright, let's sink our teeth into the meat and potatoes of Metacon's latest report. The interim report for Q3 2026 hit the newsstands, but it's what's lurking behind the numbers that tells the real story. With all the green energy buzz, Metacon's report is a mixed bag, reflecting their uphill journey in hydrogen pursuits and...

Continue Reading
Adient Boosts Buyback, Shields Valuable Tax Assets

Updated Category News Views 16

Adient's Aggressive Buyback and Tax Strategy Well, it looks like Adient's not just sitting on its hands. They've not only opened up the cash taps with a $400 million increase in their share repurchase authorization but also shored up their defenses with a Tax Benefits Preservation Plan. You know, when a company dishes out that kind of cash, it tells you they see some...

Continue Reading

Top 5 Most Recently Viewed Articles

Alter Wolff Foley & Stutman LLP Achieves New Legal Milestones

Updated Category News Views 197

Alter Wolff Foley & Stutman LLP Receives Prestigious Honors Alter Wolff Foley & Stutman LLP, a distinguished family and matrimonial law firm, has proudly announced that several of its esteemed attorneys have received notable recognitions in significant legal accolades. The firm, recognized for its exceptional proficiency in family law, saw its members listed among the...

Continue Reading
Groupon, Inc. Under Scrutiny: What Investors Should Know

Updated Category News Views 271

Groupon, Inc. Faces Investigation Amid Fraud Allegations Pomerantz LLP is looking into claims on behalf of investors of Groupon, Inc. (NASDAQ: GRPN). Those who have invested in Groupon should take notice and consider their options seriously. The firm is reaching out to those impacted and encourages them to step forward. What's the Basis of the Investigation? The primary...

Continue Reading
Quantum Xchange Achieves Significant FIPS 140-3 Security Milestone

Updated Category News Views 118

Quantum Xchange Secures FIPS 140-3 Certification for Phio TX Quantum Xchange is excited to announce that its innovative, crypto-agile platform, Phio TX™, has recently achieved the prestigious FIPS 140-3 certification. This certification signifies that Phio TX meets the stringent security requirements set for cryptographic modules used by the government and various...

Continue Reading
Saia Expands Footprint with New Terminals in Ohio and Kentucky

Updated Category News Views 88

Saia Expands Footprint in Ohio and Kentucky Saia Inc. (NASDAQ: SAIA) is thrilled to announce its ongoing expansion efforts with the launch of three new terminals, aimed at enhancing service availability and efficiency. This exciting development includes the opening of a facility in Akron, Ohio, and two additional locations in Bowling Green and Paducah, Kentucky, which are...

Continue Reading
Constellation Brands Stock Faces Rough Waters at 52-Week Low

Updated Category News Views 121

Constellation Brands Stock Experiences Significant Low Constellation Brands Inc. (NYSE: STZ) recently reached a 52-week low, landing at $224.72. This marks a notable downturn for the beverage powerhouse, which boasts a diverse portfolio of beer, wine, and spirits. Despite this decline, the company maintains a commendable gross profit margin of 51%, remaining resilient...

Continue Reading